Tuesday 22 September 2015

Cohero Health Aims To Improve Patient Care For The 26 Million American Asthma Sufferers

Cohero Health, a startup that aims to improve care and medicine adherence for people with respiratory issues just debuted its comprehensive connected health platform for asthma patients on stage at TechCrunch Disrupt San Francisco 2015. Starting today, anyone with asthma is encouraged to sign up to become an early user.

In the U.S. alone, 26 million people suffer from asthma, according to the American Lung Association. Cohero Health’s ultimate mission is to enable seamless, automated, end-to-end patient to provider integrated respiratory care management.

Cohero Health plans to accomplish this through two products: a medication inhaler sensor with mobile software to track adherence and a mobile spirometer to measure and monitor lung function. The inhaler sensor, called HeroTracker, is basically a jacket that fits over the inhaler to track patient adherence. Meanwhile, the mobile spirometer measures lung function and tracks Forced Vital Capacity and Forced Expiratory Volume, which is the speed and volume of breath over time. In June, Cohero Health received FDA clearance for its mobile spirometer, which allows asthma patients to track their lung function at home.

“We’re super excited about the FDA clearance,” Cohero Health CEO and Co-Founder Melissa Manice told me ahead of her presentation at Disrupt. “What’s crazy is that, we all know asthma is chronic, so the best you can do is maintain it and hope to treat it so your condition improves. What we hope to do is eradicate these hospitalizations. The main reason why there are these hospitalizations is because patients are not adherent on their control medications.”

With a PhD in Clinical and Translational Research and a Master’s in Public Health, Manice knows what she’s talking about. In her PhD research, Manice studied asthma and how patients’ failure to regularly take their inhalers as prescribed resulted in poor health, hospitalizations and tons of money spent in health care costs.

Cohero Health’s principle business model is B2B, meaning that it plans to collaborate with pharmaceutical companies, insurance companies interested in improving patient outcomes and reducing costs associated with hospitalizations, and clinics that still rely on the super expensive, chunky equipment currently used to measure a patient’s lung function. Down the road, Cohero Health wants to consolidate the inhaler sensor and spirometer into one device.

“Digital technology has an opportunity to improve chronic diseases in the same way it’s driven movement in the wellness space,” Manice said.

As someone born with asthma who’s been hospitalized several times, I’m personally super eager to try this out and have signed up to be an early user.

View the original content and more from this author here: http://ift.tt/1FYU4tX



from health IT caucus http://ift.tt/1OrxDpe
via IFTTT

No comments:

Post a Comment